| Filed On | Filing |
|---|---|
| 30 Jun 2026 |
Form 4: Grosso Christopher G, Director
Acquired 0 Convertible Promissory Note (Open Market Purchase) |
| 30 Apr 2026 |
Form 4: Grosso Christopher G, Director
Acquired 581,536 shares (Other Transaction) |
| 15 Oct 2025 |
Form 4: Atcher Robert, Director
Received 250,000 shares as a grant or award |
| 15 Oct 2025 |
Form 4: Laflin Steve, Director
Granted 500,000 Stock Option (Right to Buy) |
| 15 Oct 2025 |
Form 4: Grosso Christopher G, Director
Granted 500,000 Stock Option (Right to Buy) |
| 14 Oct 2025 |
Form 4: Bagerdjian Shahe, Director
Granted 37,500,000 Restricted Stock Units |
| 27 May 2025 |
Form 4: Bagerdjian Shahe, Director
Bought 140,000 shares ($7K) |
| 30 Apr 2025 |
Form 4: Grosso Christopher G, Director
Granted 1,500,000 Stock Option (Right to Buy) |
| 30 Apr 2025 |
Form 4: Grosso Christopher G, Director
Acquired 604,800 shares (Other Transaction) |
| 28 Apr 2025 |
Form 4: Bagerdjian Shahe, Director
Gave up 583,229 shares to cover exercise price or tax ($29.2K) |
| 10 Mar 2025 |
Form 4: Bagerdjian Shahe, Director
Bought 177,000 shares ($8.85K) |
| 22 Nov 2024 |
Form 4: Bagerdjian Shahe, Director
Bought 100,000 shares ($4K) |
| 22 Nov 2024 |
Form 4: Cox W Matthew, Chief Financial Officer
Bought 30,000 shares ($1.2K) · Bought 60,000 shares ($1.8K) |
| 18 Nov 2024 |
Form 4: Grosso Christopher G, Director
Bought 401,117 shares ($12K) |
| 20 Sep 2024 |
Form 4: Grosso Christopher G, Director
Bought 800,000 shares ($24K) |
| 17 Sep 2024 |
Form 4: Bagerdjian Shahe, Director
Received 350,000 shares as a grant or award |
| 18 Jun 2024 |
Form 4: Bagerdjian Shahe, Director
Gave up 531,750 shares to cover exercise price or tax ($21.3K) · Bought 250,000 shares ($10K) |
| 18 Jun 2024 |
Form 4: Cox W Matthew, Chief Financial Officer
Bought 239,669 shares ($9.59K) |
| 06 Mar 2024 |
Form 4: Atcher Robert, Director
Received 750,000 shares as a grant or award |
| 15 Dec 2023 |
Form 4: Cox W Matthew, Chief Financial Officer
Bought 250,000 shares ($6.25K) |
Loading...